Tuberculosis News and Research

Latest Tuberculosis News and Research

FIND, NUS collaborate to identify novel biomarkers for TB diagnosis

A research team from the National University of Singapore (NUS) Singapore Lipidomics Incubator (SLING) is collaborating with the Foundation for Innovative New Diagnostics (FIND) to identify novel target molecules to be employed as biomarkers for the detection of active tuberculosis.

15 Dec 2011

Goal of near-zero malaria deaths attainable with continued will, resources

In this TIME "Ideas" opinion piece, David Bowen, CEO of Malaria No More, writes that with the right resources and political will, an end to malaria is possible.

15 Dec 2011

Paul Farmer discusses equity in international health with Scientific American

In this Scientific American "60-Second Health" podcast, journalist Katherine Harmon interviews Paul Farmer, a Harvard professor and co-founder of the non-profit Partners in Health, who is "famous for his health work in Haiti."

15 Dec 2011

First mobile safety lab for South African patients with AIDS and TB

The first mobile safety laboratory to operate under Biosafety Level 3 has been in use in South Africa since May 2011. As development of the Fraunhofer Institute for Biomedical Engineering in St. Ingbert, this special truck is used for testing and advising patients with AIDS and tuberculosis. The mobile laboratory can save patients' lives in remote areas because it cuts the waiting time between diagnosis and the start of treatment to just one day.

15 Dec 2011

U.S. DoD awards $11M to study two different ways to treat PTSD in war veterans

A team of researchers who have pioneered novel treatments for post-traumatic stress disorder (PTSD) has been awarded an $11 million, four-year grant from the U.S. Department of Defense to investigate the differences between virtual reality and traditional prolonged exposure therapy.

14 Dec 2011

Research describes advantages of new vaccine adjuvant

New research from the laboratory of Dr. Elizabeth Leadbetter at the Trudeau Institute may lead to a whole new class of vaccines. Dr. Leadbetter's lab has discovered new properties of a potential vaccine adjuvant that suggest it could be useful for enhancing protection against a number of different infections.

13 Dec 2011

Incidence of TB diagnosis is increased in mothers postpartum

The incidence of tuberculosis (TB) diagnosis is significantly increased in mothers postpartum, suggesting a potential new population to target for screening, according to a new UK-wide cohort study.

12 Dec 2011

New guidelines for managing latent tuberculosis from CDC

The U.S. Centers for Disease Control and Prevention (CDC) has released new guidelines on treating so-called “latent” tuberculosis (TB) infection in the United States. They suggest the course of the therapy from about 9 months could be shortened to 3 months.

11 Dec 2011

Progress in AIDS fight in peril as governments renege on funding pledges

In this Toronto Star opinion piece, Richard Elliott, executive director of the Canadian HIV/AIDS Legal Network, and Nicci Stein, executive director of the Interagency Coalition on AIDS and Development, discuss how progress made in the fight against HIV/AIDS over the last 30 years "is in peril, due to governments reneging on repeated promises to fund the fight against the pandemic."

9 Dec 2011

MCC invests $122M in Lesotho health system to address key challenges, including HIV, TB

"The Millennium Challenge Corporation (MCC), through its partnership with the Millennium Challenge Account-Lesotho, is helping Lesotho address key challenges in its health sector through a $122 million investment in health infrastructure and health systems," IIP Digital reports.

9 Dec 2011

Shorter, effective treatment for latent TB infection

Research, led by Timothy Sterling, M.D., professor of Medicine at Vanderbilt University Medical Center, has led to an important change in CDC recommendations in the regimen for prevention of the centuries-old scourge, tuberculosis (TB).

9 Dec 2011

Pharmacyclics, Janssen partner to develop and market PCI-32765 anti-cancer compound

Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, announced today that it has executed an agreement with Pharmacyclics, Inc. to jointly develop and market the anti-cancer compound, PCI-32765.

9 Dec 2011

Global health R&D funding from wealthy nations fell 6% in 2010, annual G-FINDER report finds

"A group that tracks funding for neglected diseases released its fourth annual report Wednesday, showing for the first time since 2007 a decrease in government and public spending in global health research and development," the Center for Global Health Policy's "Science Speaks" blog reports.

8 Dec 2011

Updated data from Novartis Afinitor plus everolimus Phase III study on advanced breast cancer

Updated results of a Phase III study of Afinitor (everolimus) tablets plus exemestane, a hormonal therapy, show everolimus provided additional time women with advanced breast cancer lived without their disease progressing.

8 Dec 2011

Fully funding global health initiatives critical in AIDS fight

"With donor support flagging around the world, U.S. leadership is crucial. Congress must fully fund its global health programs, especially the Global Fund" to Fight AIDS, Tuberculosis and Malaria, Joyce Kamwana, a Global Fund "HERE I AM" campaign ambassador, writes in The Hill's "Congress Blog."

6 Dec 2011

Cayetano Heredia, UT Southwestern sign five-year affiliation agreement

UT Southwestern Medical Center and the Universidad Peruana Cayetano Heredia in Peru have signed a five-year affiliation agreement that establishes an exchange program for medical students and related educational opportunities.

6 Dec 2011

Novartis to showcase 160 presentations on breast cancer, hematological disease drugs at SABCS and ASH

Novartis Pharmaceuticals Corporation will showcase more than one hundred and sixty presentations on data from its robust oncology portfolio at two key medical congresses this month, demonstrating significant advances for patients with cancers and hematological diseases.

3 Dec 2011

Product Development Partnerships 'essential' in fight against global diseases

"If the momentum gained in the last few years" in fighting global diseases such as HIV, tuberculosis (TB), malaria, measles, and meningitis "is any indicator of our future trajectory, we are standing on the threshold of a revolutionary change in the state of global health," Wendy Taylor, senior adviser of Innovative Finance and Public Private Partnerships at USAID, and David Cook, executive vice president and COO of the International AIDS Vaccine Initiative (IAVI),

3 Dec 2011

Opinion pieces, editorial recognize World AIDS Day

Rear Admiral Susan Blumenthal and Ashley Grosso, Huffington Post's "Impact": Blumenthal, senior policy and medical adviser at amfAR, The Foundation for AIDS Research, and Grosso, an Allan Rosenfield fellow at amfAR, outline steps they feel necessary to reach the goal of an AIDS-free generation.

3 Dec 2011

South African President introduces National Strategic Plan on HIV, STIs, TB

South African President Jacob Zuma in a speech on Thursday to mark World AIDS Day introduced a new five-year National Strategic Plan on HIV, sexually transmitted infections (STIs) and tuberculosis (TB), which "calls for stepped-up prevention efforts to halve new infections of HIV and tuberculosis by 2016 and to put 80 percent of eligible patients on antiretroviral drugs to fight AIDS," Agence France-Presse reports.

3 Dec 2011